Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.

Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M.

Oncoimmunology. 2015 May 7;4(8):e1026529. eCollection 2015 Aug.

2.

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.

Herzog TJ, Armstrong DK, Brady MF, Coleman RL, Einstein MH, Monk BJ, Mannel RS, Thigpen JT, Umpierre SA, Villella JA, Alvarez RD.

Gynecol Oncol. 2014 Jan;132(1):8-17. doi: 10.1016/j.ygyno.2013.11.008. Epub 2013 Nov 15.

3.

Usual adult body mass index is not predictive of ovarian cancer survival.

Moysich KB, Baker JA, Menezes RJ, Jayaprakash V, Rodabaugh KJ, Odunsi K, Beehler GP, McCann SE, Villella JA.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):626-8. No abstract available.

4.

Consumption of black tea or coffee and risk of ovarian cancer.

Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA, Moysich KB.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):50-4.

PMID:
17291231
5.

HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications.

Villella JA, Cohen S, Smith DH, Hibshoosh H, Hershman D.

Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1897-902.

PMID:
17009989
6.

Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.

Villella JA, Parmar M, Donohue K, Fahey C, Piver MS, Rodabaugh K.

Gynecol Oncol. 2006 Sep;102(3):475-9. Epub 2006 Feb 13.

PMID:
16473397
7.

Regular analgesic use and risk of endometrial cancer.

Moysich KB, Baker JA, Rodabaugh KJ, Villella JA.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2923-8.

8.

Rhabdomyosarcoma of the cervix in sisters with review of the literature.

Villella JA, Bogner PN, Jani-Sait SN, Block AM, Lele S.

Gynecol Oncol. 2005 Dec;99(3):742-8. Epub 2005 Oct 7. Review.

PMID:
16214206
9.

Tumors of low malignant potential arising in the fallopian tube: case reports.

Villella JA, Pauli SA, Wang J, Intengan M, Lele S.

Eur J Gynaecol Oncol. 2005;26(3):327-9.

PMID:
15991538
10.

Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary.

Levine DA, Villella JA, Poynor EA, Soslow RA.

Gynecol Oncol. 2004 Aug;94(2):597-9.

PMID:
15297213
11.

Outcomes of endometrial cancer patients undergoing surgery with gynecologic oncology involvement.

Pearl ML, Villella JA, Valea FA, DiSilvestro PA, Chalas E.

Obstet Gynecol. 2002 Oct;100(4):724-9.

PMID:
12383541
12.

Comparison of tolerance of combination carboplatin and paclitaxel chemotherapy by age in women with ovarian cancer.

Villella JA, Chaudhry T, Pearl ML, Valea F, DiSilvestro PA, Pollack S, Chalas E.

Gynecol Oncol. 2002 Sep;86(3):316-22.

PMID:
12217754

Supplemental Content

Loading ...
Support Center